Woman allegedly chokes on sandwich, performs Heimlich on self
RICHMOND, Ind. (WDTN) — A Preble County woman is speaking out after allegedly performing the Heimlich maneuver on herself after eating a sandwich from an area restaurant.
Patricia Webster claims she obtained a chicken salad sandwich from a McAlister's Deli location in Richmond, Indiana in May. Webster said she was eating the sandwich in her vehicle and started to choke after biting into what she later discovered was an avocado pit.
'It was just instantaneous,' said Webster. 'It just kind of popped and went into the back of my throat and I instantly couldn't breathe.'
The Preble County woman said she was forced to exit her car to take matters into her own hands.
She told WDTN she performed the Heimlich maneuver on herself several times on the trunk of her vehicle, which ended up working.
'The first couple times I was just trying to do it with one hand, and I just couldn't get enough,' Webster said. 'So I finally just took both, and I just kind of, like, rammed into it, but, you know, at a quicker speed.'
According to Webster, she has attempted to receive an answer on how this could have happened, but has never been contacted.
Although Webster says she is grateful to be alive following the scary incident, she wants the restaurant to investigate the cause behind how the pit ended in her sandwich. She also wants the issue to be addressed so another customer doesn't have the same or similar experience.
WDTN reached out to the location and company to see if Webster's complaint will be investigated. We have not yet heard back.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Kettering Health patients speak out on aftermath of cyberattack
DAYTON, Ohio (WDTN) — Across the Miami Valley, patients with Kettering Health say they are feeling the impact of the May cyberattack. While Kettering Health leaders say the technical issues are resolved, many people say things are far from normal at their local offices and hospitals. Where does Kettering Health stand nearly two weeks after cyberattack? 2 NEWS spoke with several Kettering Health patients, who say that some local facilities in the health network still do not have working phones and are relying on paper forms — causing staff to face additional obstacles as they work to take care of their patients. 'I just, I just say thank you to all of them because they're amazing people,' said Anita Sackenheim, Kettering Health patient. Sackenheim says Kettering Health employees are working even harder than usual as they deal with the after effects of the May 20 cyberattack. The loss of access to several major online systems following the attack has resulted in changes at local offices and hospitals until a full recovery can be made. Patients say they can see how much more work its made for hospital staff as they continue to provide care. 'They would run it to the lab, they would run to the ER to get what they needed, then they would run to all the different places where, usually, they would do it through the computer,' said Erin Hoffman, Kettering Health patient. Several patients tell 2 NEWS that facilities are being forced to use paper forms, causing longer wait times. Without computer access, staff must fill out lengthy forms by hand, which can be more time-consuming. 'I actually felt sorry for the staff, you know, because I knew that it was much more work for them and it was something that they were not used to doing,' said Sackenheim. Many patients say they are also struggling to get their prescription medication filled, since oftentimes patients request refills through MyChart or by phone — all systems that were affected by the cyberattack shutdown. ' Hacker group allegedly behind Kettering Health leak, data posted to deep web Some patients tell 2 NEWS that they have had to go to their doctor's office in person to get a written prescription and then take that to the pharmacy, since the pharmacies themselves cannot get into contact with hospitals and doctor's offices. Many echo the sentiment that this is a scary situation, especially for elderly patients. 'Total lack of communication, you know, any issue is very frightening,' said Kerry Corthell, Kettering Health patient. Corthell says those who are able to make it to their doctor's offices are met with delays and long wait times. 'There were a lot of us old folks in the office, who were just standing in a long line, waiting and waiting until somebody could talk to us,' said Corthell. Kettering Health officials say they are still working toward getting back to normal operations, but there is no clear time frame for how long the effects of the cyberattack could linger. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
2 hours ago
- Yahoo
Local pharmacist saves two lives in one day
DAYTON, Ohio (WDTN) — A Kroger pharmacist is being recognized for her heroic acts last week. Kroger is commending one of its pharmacists for saving not one, but two lives during her work shift last week. According to Kroger, Pharmacist Megan Alt was attending to the drive-thru when a customer at the window began experiencing convulsions. Alt grabbed an epi pen, ran out the fire exit and administered the medication before calling 911. During that same shift, a security guard alerted Alt to an individual passed out in the store's restroom. Alt was able to administer Narcan and once again dialed 911 to save the person's life. 'We're so proud of Megan for taking extraordinary measures to care for her patients when they needed it most,' said Kroger. Alt is originally from Perrysburg and earned a bachelor's degree in pharmaceutical science in 2018 from Cedarville University. She then earned her Doctor of Pharmacy degree from Cedarville in 2021. The university is also praising Alt for her quick response to those in need. 'The Cedarville University School of Pharmacy, along with Megan's colleagues at Kroger, congratulate Megan on serving others well,' said Cedarville University. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
3 hours ago
- Yahoo
H.C. Wainwright Initiates Coverage of Akebia Therapeutics (AKBA) With Buy Rating
Matthew Caufield, an analyst from H.C. Wainwright, initiated coverage of Akebia Therapeutics, Inc. (NASDAQ:AKBA) with a Buy rating and a $8 price target, on June 4. The analyst gave the optimistic rating due to the company's VAFSEO product and its potential in the CKD anemia market. VAFSEO is an approved treatment for anemia in adults with chronic kidney disease on dialysis. According to the analyst, the treatment is gaining considerable momentum among dialysis organizations, and this trend is anticipated to support near-term growth. He expects VAFSEO's ongoing launch to offset the effect of generics on AURYXIA, another product by Akebia Therapeutics, Inc. (NASDAQ:AKBA) that deals with hyperphosphatemia. A biopharmaceutical team in a laboratory analyzing new compounds to develop therapeutics. The analyst also reasoned that Akebia Therapeutics, Inc. (NASDAQ:AKBA) is positioned for success as it has secured contracts that cover almost all dialysis patients in the US. VAFSEO offers flexibility in its dosing regimen, ranging from 150mg to 600mg, making it a factor that allows for personalized treatment and potentially growing prescriptions. Caufield pointed out VAFSEO's oral administration as another reason supporting the optimistic rating, giving it an advantage over existing therapies, such as iron supplementation and erythropoiesis-stimulating agents. Akebia Therapeutics, Inc. (NASDAQ:AKBA) is a biopharmaceutical company that develops and commercializes drugs to treat metabolic and renal diseases. While we acknowledge the potential of AKBA as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None. Sign in to access your portfolio
